We are live on ! Find out more
PRVL

Prevail Therapeutics Inc. Common Stock
PRVL

Delisted

PRVL was delisted on the 21st of January, 2021.

Name Holding Trade Value Shares
Change
Change in
Stake
O
1
OrbiMed
New York
$170M
RCM
2
RA Capital Management
Massachusetts
$41.3M +$7.03M +619,980 +23%
EC
3
EcoR1 Capital
California
$29.4M
BC
4
Boxer Capital
California
$13.8M
Citadel Advisors
5
Citadel Advisors
Florida
$13.1M -$1.32M -116,063 -10%
Fidelity Investments
6
Fidelity Investments
Massachusetts
$10.7M +$623K +55,000 +7%
OFM
7
Omega Fund Management
Massachusetts
$8.21M
BI
8
BVF Inc
California
$8.06M
Adage Capital Partners
9
Adage Capital Partners
Massachusetts
$6.29M -$1.4M -123,158 -19%
BlackRock
10
BlackRock
New York
$5.46M +$3.91M +344,734 +345%
CI
11
Clal Insurance
Israel
$3.59M -$181K -16,000 -5%
Bank of America
12
Bank of America
North Carolina
$2.95M +$2.72M +240,260 +120,130%
Vanguard Group
13
Vanguard Group
Pennsylvania
$2.88M +$1.79M +157,556 +205%
Bank of New York Mellon
14
Bank of New York Mellon
New York
$2.58M +$2.38M +210,071 New
LCM
15
Laurion Capital Management
New York
$1.25M -$1.11M -98,051 -49%
SFM
16
Sphera Funds Management
Israel
$1.11M -$461K -40,713 -31%
Northern Trust
17
Northern Trust
Illinois
$1.03M +$786K +69,386 +487%
Geode Capital Management
18
Geode Capital Management
Massachusetts
$1M +$925K +81,666 New
UBS Group
19
UBS Group
Switzerland
$952K -$119K -10,485 Closed
DCM
20
DAFNA Capital Management
California
$921K
State Street
21
State Street
Massachusetts
$763K +$704K +62,119 New
Millennium Management
22
Millennium Management
New York
$618K -$1.47M -129,915 -72%
AS
23
Altshuler Shaham
Israel
$615K +$572K +50,460 New
Nuveen
24
Nuveen
North Carolina
$299K +$277K +24,407 New
Charles Schwab
25
Charles Schwab
California
$193K +$177K +15,662 New